Aftab Dana
SEC CIK 1959132 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EXEL | EXELIXIS, INC. | EVP, Research, Development | 594.7K | — | $16.67M | 41 | 2023-01-05 | 2026-05-26 |
Most active insiders at EXEL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Aftab Dana | EVP, Research, Development | — | $7.70M |
| 2 | Haley Patrick J. | EVP, Commercial | — | $7.60M |
| 3 | Smith Julie | Dir | — | $4.69M |
| 4 | WYSZOMIERSKI JACK L | Dir | — | $4.58M |
| 5 | Senner Christopher J. | EVP, CFO | — | $4.56M |
| 6 | PAPADOPOULOS STELIOS | Dir | — | $4.36M |
| 7 | POSTE GEORGE | Dir | — | $2.74M |
| 8 | Beckerle Mary C | Dir | — | $1.93M |
| 9 | Oliver Bob | Dir | — | $1.33M |
| 10 | Caligan Partners LP | Dir, See Remarks | $1.19M | — |
Transactions 41
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-05-28 18:25 | 2026-05-26 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | S - Sale | $50.35 | -43.5K | 594.7K | -7% | -$2.19M | |
| 2026-05-19 18:58 | 2026-05-15 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | F - Tax | $51.10 | -30.6K | 638.2K | -5% | -$1.56M | |
| 2026-03-02 | 2026-02-26 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +52.0K | 668.1K | +8% | $0 | |
| 2026-02-26 | 2026-02-24 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | S - Sale | $44.50 | -47.9K | 616.1K | -7% | -$2.13M | |
| 2026-02-23 | 2026-02-19 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | S - Sale | $44.35 | -29.9K | 664.0K | -4% | -$1.32M | |
| M | 2026-02-18 | 2026-02-15 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | F - Tax | $43.92 | -39.2K | 706.6K | -5% | -$1.72M |
| 2026-01-16 | 2026-01-15 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +119.6K | 760.4K | +19% | $0 | |
| 2026-01-16 | 2026-01-15 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | F - Tax | $45.23 | -27.3K | 733.1K | -4% | -$1.23M | |
| 2025-11-24 | 2025-11-21 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | G - Gift | $0.00 | -24.0K | 640.8K | -4% | $0 | |
| 2025-11-13 | 2025-11-11 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | S - Sale | $42.50 | -48.4K | 664.8K | -7% | -$2.06M | |
| 2025-10-10 | 2025-10-08 | EXEL | EXELIXIS, INC. | Aftab Dana | EVP, Research, Development | A - Grant | $0.00 | +50.7K | 713.2K | +8% | $0 | |
| 2025-05-16 | 2025-05-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $44.65 | -30.7K | 662.5K | -4% | -$1.37M | |
| 2025-05-05 | 2025-05-01 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $39.00 | -1,508 | 693.2K | -0.2% | -$58.8K | |
| 2025-03-31 | 2025-03-31 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +132.8K | 693.9K | +24% | $0 | |
| 2025-02-28 | 2025-02-26 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +49.2K | 561.1K | +10% | $0 | |
| 2025-02-26 | 2025-02-24 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $36.75 | -27.0K | 511.9K | -5% | -$991.8K | |
| M | 2025-02-19 | 2025-02-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $35.00 | -28.7K | 551.6K | -5% | -$1.01M |
| 2025-01-17 | 2025-01-16 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +104.1K | 590.2K | +21% | $0 | |
| 2025-01-17 | 2025-01-16 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $37.27 | -22.6K | 567.6K | -4% | -$841.2K | |
| 2024-11-19 | 2024-11-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $35.05 | -12.8K | 486.1K | -3% | -$450.0K | |
| D | 2024-11-07 | 2024-11-05 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale+OE | $35.00 | -97.0K | 498.9K | -16% | -$3.39M |
| D | 2024-11-07 | 2024-11-05 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $18.80 | +97.0K | 595.9K | +19% | +$1.82M |
| 2024-11-01 | 2024-10-30 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $31.40 | -1,162 | 498.9K | -0.2% | -$36.5K | |
| 2024-08-14 | 2024-08-12 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $27.06 | -20.9K | 500.1K | -4% | -$565.1K | |
| D | 2024-08-09 | 2024-08-07 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale+OE | $25.00 | -95.0K | 521.0K | -15% | -$2.38M |
| D | 2024-08-09 | 2024-08-07 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $24.41 | +95.0K | 616.0K | +18% | +$2.32M |
| M | 2024-05-17 | 2024-05-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $20.99 | -22.6K | 529.6K | -4% | -$474.5K |
| 2024-02-27 | 2024-02-23 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +63.4K | 542.4K | +13% | $0 | |
| 2024-02-16 | 2024-02-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $20.39 | -10.6K | 479.0K | -2% | -$216.7K | |
| 2024-01-16 | 2024-01-11 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +63.2K | 501.3K | +14% | $0 | |
| 2024-01-16 | 2024-01-11 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $22.86 | -11.6K | 489.7K | -2% | -$265.3K | |
| 2023-09-08 | 2023-09-06 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +50.7K | 450.6K | +13% | $0 | |
| 2023-09-08 | 2023-09-06 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $22.27 | -12.6K | 438.0K | -3% | -$279.7K | |
| 2023-09-01 | 2023-08-30 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale | $22.47 | -4,600 | 399.9K | -1% | -$103.4K | |
| 2023-08-17 | 2023-08-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $21.51 | -6,280 | 404.5K | -2% | -$135.1K | |
| M | 2023-05-17 | 2023-05-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $19.18 | -10.5K | 416.9K | -2% | -$201.2K |
| 2023-04-05 | 2023-04-03 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +68.3K | 419.8K | +19% | $0 | |
| DM | 2023-03-01 | 2023-02-27+ | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | M - OptEx | $14.74 | +82.5K | 434.0K | +23% | +$1.22M |
| DM | 2023-03-01 | 2023-02-27+ | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | S - Sale+OE | $17.50 | -82.5K | 351.5K | -19% | -$1.44M |
| 2023-02-17 | 2023-02-15 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | F - Tax | $18.08 | -1,529 | 351.5K | -0.4% | -$27.6K | |
| 2023-01-09 | 2023-01-05 | EXEL | EXELIXIS, INC. | Aftab Dana | CSO, EVP Disc, Trans Research | A - Grant | $0.00 | +100.0K | 353.0K | +40% | $0 |
Purchase Sale Sale after option exercise All abbreviations